Exact Mass: 487.1885168
Exact Mass Matches: 487.1885168
Found 475 metabolites which its exact mass value is equals to given mass value 487.1885168,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
YC 170
C28H26ClN3O3 (487.1662596000001)
Myxothiazol
A 2,4-bi-1,3-thiazole substituted at the 4-position with a (1E,3S,4R,5E)-7-amino-3,5-dimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl] group and at the 2-position with a (2S,3E,5E)-7-methylocta-3,5-dien-2-yl group. It is an inhibitor of coenzyme Q - cytochrome c reductase. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
Dasatinib
C22H26ClN7O2S (487.1557126000001)
Dasatinib is only found in individuals that have used or taken this drug. It is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of Dasatinib, are BCRABL, SRC, Ephrins and GFR.Dasatinib, at nanomolar concentrations, inhibits the following kinases: BCR-ABL, SRC family (SRC, LCK, YES, FYN), c-KIT, EPHA2, and PDGFR&beta. Based on modeling studies, dasatinib is predicted to bind to multiple conformations of the ABL kinase. In vitro, dasatinib was active in leukemic cell lines representing variants of imatinib mesylate sensitive and resistant disease. Dasatinib inhibited the growth of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) cell lines overexpressing BCR-ABL. Under the conditions of the assays, dasatinib was able to overcome imatinib resistance resulting from BCR-ABL kinase domain mutations, activation of alternate signaling pathways involving the SRC family kinases (LYN, HCK), and multi-drug resistance gene overexpression. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ac-Ser-Asp-Lys-Pro-OH
Ac-Ser-Asp-Lys-Pro-OH, also known as Ac-ser-asp-lys-pro or AcSDKP-NH2, is classified as a member of the Oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Ac-Ser-Asp-Lys-Pro-OH is considered to be practically insoluble (in water) and acidic D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors C26170 - Protective Agent
Acetyl-Ser-Asp-Lys-Pro
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors
2,2,2-Trifluoro-N-((1R,2S)-1-((1-(4-fluorophenyl)-1H-indazol-5-yl)oxy)-1-(3-methoxyphenyl)-2-propanyl)acetamide
C25H21F4N3O3 (487.15189640000006)
(2S)-3-[[2-[(5R)-3-(4-Carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]acetyl]amino]-2-[(3-methylphenyl)sulfonylamino]propanoic acid
Methylsulfonyl 4-[(2-carbamimidoyl-3,4-dihydro-1H-isoquinolin-7-yl)oxymethyl]-1-pyridin-4-ylpiperidine-4-carboxylate
C23H29N5O5S (487.18893040000006)
Malvidin 3-alpha-L-galactoside
Malvidin 3-alpha-l-galactoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Malvidin 3-alpha-l-galactoside can be found in highbush blueberry, which makes malvidin 3-alpha-l-galactoside a potential biomarker for the consumption of this food product.
Pemigatinib
C24H27F2N5O4 (487.2031006000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
Sarecycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D003879 - Dermatologic Agents
stesakine-9-O-beta-D-glucopyranoside
C25H29NO9 (487.18422240000007)
spiruchostatin B
C21H33N3O6S2 (487.18106780000005)
A spiruchostatin with molecular formula C21H33N3O6S2 originally isolated from a Pseudomonas culture broth. D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors
4-hydroxy-3-methoxyphenylacetonitrile 4-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside|adenophoraside B
C21H29NO12 (487.16896740000004)
4-[[4-hydroxy-2-(2-methylpropyl)-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione
C27H29N5O4 (487.22194340000004)
Ala Asp Pro Trp
Ala Asp Trp Pro
Ala Phe His Asn
Ala Phe Asn His
Ala His Phe Asn
Ala His Asn Phe
Ala Asn Phe His
Ala Asn His Phe
Ala Pro Asp Trp
Ala Pro Trp Asp
Ala Trp Asp Pro
Ala Trp Pro Asp
Cys Asp His Asn
Cys Asp Asn His
Cys His Asp Asn
Cys His Lys Thr
C19H33N7O6S (487.2212918000001)
Cys His Asn Asp
Cys His Gln Thr
C18H29N7O7S (487.18490840000004)
Cys His Thr Lys
C19H33N7O6S (487.2212918000001)
Cys His Thr Gln
C18H29N7O7S (487.18490840000004)
Cys Lys His Thr
C19H33N7O6S (487.2212918000001)
Cys Lys Thr His
C19H33N7O6S (487.2212918000001)
Cys Asn Asp His
Cys Asn His Asp
Cys Gln His Thr
C18H29N7O7S (487.18490840000004)
Cys Gln Thr His
C18H29N7O7S (487.18490840000004)
Cys Thr His Lys
C19H33N7O6S (487.2212918000001)
Cys Thr His Gln
C18H29N7O7S (487.18490840000004)
Cys Thr Lys His
C19H33N7O6S (487.2212918000001)
Cys Thr Gln His
C18H29N7O7S (487.18490840000004)
Asp Ala Pro Trp
Asp Ala Trp Pro
Asp Cys His Asn
Asp Cys Asn His
Asp Glu Lys Pro
Asp Glu Pro Lys
Asp Glu Pro Gln
C19H29N5O10 (487.19143340000005)
Asp Glu Gln Pro
C19H29N5O10 (487.19143340000005)
Asp His Cys Asn
Asp His Asn Cys
Asp Lys Glu Pro
Asp Lys Pro Glu
Asp Asn Cys His
Asp Asn His Cys
Asp Pro Ala Trp
Asp Pro Glu Lys
Asp Pro Glu Gln
C19H29N5O10 (487.19143340000005)
Asp Pro Lys Glu
Asp Pro Gln Glu
C19H29N5O10 (487.19143340000005)
Asp Pro Trp Ala
Asp Gln Glu Pro
C19H29N5O10 (487.19143340000005)
Asp Gln Pro Glu
C19H29N5O10 (487.19143340000005)
Asp Trp Ala Pro
Asp Trp Pro Ala
Glu Asp Lys Pro
Glu Asp Pro Lys
Glu Asp Pro Gln
C19H29N5O10 (487.19143340000005)
Glu Asp Gln Pro
C19H29N5O10 (487.19143340000005)
Glu Glu Asn Pro
C19H29N5O10 (487.19143340000005)
Glu Glu Pro Asn
C19H29N5O10 (487.19143340000005)
Glu Gly Pro Trp
Glu Gly Trp Pro
Glu Lys Asp Pro
Glu Lys Pro Asp
Glu Asn Glu Pro
C19H29N5O10 (487.19143340000005)
Glu Asn Pro Glu
C19H29N5O10 (487.19143340000005)
Glu Pro Asp Lys
Glu Pro Asp Gln
C19H29N5O10 (487.19143340000005)
Glu Pro Glu Asn
C19H29N5O10 (487.19143340000005)
Glu Pro Gly Trp
Glu Pro Lys Asp
Glu Pro Asn Glu
C19H29N5O10 (487.19143340000005)
Glu Pro Gln Asp
C19H29N5O10 (487.19143340000005)
Glu Pro Trp Gly
Glu Gln Asp Pro
C19H29N5O10 (487.19143340000005)
Glu Gln Pro Asp
C19H29N5O10 (487.19143340000005)
Glu Trp Gly Pro
Glu Trp Pro Gly
Phe Ala His Asn
Phe Ala Asn His
Phe Gly His Gln
Phe Gly Gln His
Phe His Ala Asn
Phe His Gly Gln
Phe His Asn Ala
Phe His Gln Gly
Phe Asn Ala His
Phe Asn His Ala
Phe Gln Gly His
Phe Gln His Gly
Gly Glu Pro Trp
Gly Glu Trp Pro
Gly Phe His Gln
Gly Phe Gln His
Gly His Phe Gln
Gly His Gln Phe
Gly Pro Glu Trp
Gly Pro Trp Glu
Gly Gln Phe His
Gly Gln His Phe
Gly Trp Glu Pro
Gly Trp Pro Glu
His Ala Phe Asn
His Ala Asn Phe
His Cys Asp Asn
His Cys Lys Thr
C19H33N7O6S (487.2212918000001)
His Cys Asn Asp
His Cys Gln Thr
C18H29N7O7S (487.18490840000004)
His Cys Thr Lys
C19H33N7O6S (487.2212918000001)
His Cys Thr Gln
C18H29N7O7S (487.18490840000004)
His Asp Cys Asn
His Asp Asn Cys
His Phe Ala Asn
His Phe Gly Gln
His Phe Asn Ala
His Phe Gln Gly
His Gly Phe Gln
His Gly Gln Phe
His Lys Cys Thr
C19H33N7O6S (487.2212918000001)
His Lys Thr Cys
C19H33N7O6S (487.2212918000001)
His Met Asn Ser
C18H29N7O7S (487.18490840000004)
His Met Ser Asn
C18H29N7O7S (487.18490840000004)
His Asn Ala Phe
His Asn Cys Asp
His Asn Asp Cys
His Asn Phe Ala
His Asn Met Ser
C18H29N7O7S (487.18490840000004)
His Asn Ser Met
C18H29N7O7S (487.18490840000004)
His Gln Cys Thr
C18H29N7O7S (487.18490840000004)
His Gln Phe Gly
His Gln Gly Phe
His Gln Thr Cys
C18H29N7O7S (487.18490840000004)
His Ser Met Asn
C18H29N7O7S (487.18490840000004)
His Ser Asn Met
C18H29N7O7S (487.18490840000004)
His Thr Cys Lys
C19H33N7O6S (487.2212918000001)
His Thr Cys Gln
C18H29N7O7S (487.18490840000004)
His Thr Lys Cys
C19H33N7O6S (487.2212918000001)
His Thr Gln Cys
C18H29N7O7S (487.18490840000004)
Lys Cys His Thr
C19H33N7O6S (487.2212918000001)
Lys Cys Thr His
C19H33N7O6S (487.2212918000001)
Lys Asp Glu Pro
Lys Asp Pro Glu
Lys Glu Asp Pro
Lys Glu Pro Asp
Lys His Cys Thr
C19H33N7O6S (487.2212918000001)
Lys His Thr Cys
C19H33N7O6S (487.2212918000001)
Lys Pro Asp Glu
Lys Pro Glu Asp
Lys Thr Cys His
C19H33N7O6S (487.2212918000001)
Lys Thr His Cys
C19H33N7O6S (487.2212918000001)
Met His Asn Ser
C18H29N7O7S (487.18490840000004)
Met His Ser Asn
C18H29N7O7S (487.18490840000004)
Met Asn His Ser
C18H29N7O7S (487.18490840000004)
Met Asn Ser His
C18H29N7O7S (487.18490840000004)
Met Ser His Asn
C18H29N7O7S (487.18490840000004)
Met Ser Asn His
C18H29N7O7S (487.18490840000004)
Asn Ala Phe His
Asn Ala His Phe
Asn Cys Asp His
Asn Cys His Asp
Asn Asp Cys His
Asn Asp His Cys
Asn Glu Glu Pro
C19H29N5O10 (487.19143340000005)
Asn Glu Pro Glu
C19H29N5O10 (487.19143340000005)
Asn Phe Ala His
Asn Phe His Ala
Asn His Ala Phe
Asn His Cys Asp
Asn His Asp Cys
Asn His Phe Ala
Asn His Met Ser
C18H29N7O7S (487.18490840000004)
Asn His Ser Met
C18H29N7O7S (487.18490840000004)
Asn Met His Ser
C18H29N7O7S (487.18490840000004)
Asn Met Ser His
C18H29N7O7S (487.18490840000004)
Asn Pro Glu Glu
C19H29N5O10 (487.19143340000005)
Asn Ser His Met
C18H29N7O7S (487.18490840000004)
Asn Ser Met His
C18H29N7O7S (487.18490840000004)
Pro Ala Asp Trp
Pro Ala Trp Asp
Pro Asp Ala Trp
Pro Asp Glu Lys
Pro Asp Glu Gln
C19H29N5O10 (487.19143340000005)
Pro Asp Lys Glu
Pro Asp Gln Glu
C19H29N5O10 (487.19143340000005)
Pro Asp Trp Ala
Pro Glu Asp Lys
Pro Glu Asp Gln
C19H29N5O10 (487.19143340000005)
Pro Glu Glu Asn
C19H29N5O10 (487.19143340000005)
Pro Glu Gly Trp
Pro Glu Lys Asp
Pro Glu Asn Glu
C19H29N5O10 (487.19143340000005)
Pro Glu Gln Asp
C19H29N5O10 (487.19143340000005)
Pro Glu Trp Gly
Pro Gly Glu Trp
Pro Gly Trp Glu
Pro Lys Asp Glu
Pro Lys Glu Asp
Pro Asn Glu Glu
C19H29N5O10 (487.19143340000005)
Pro Gln Asp Glu
C19H29N5O10 (487.19143340000005)
Pro Gln Glu Asp
C19H29N5O10 (487.19143340000005)
Pro Trp Ala Asp
Pro Trp Asp Ala
Pro Trp Glu Gly
Pro Trp Gly Glu
Gln Cys His Thr
C18H29N7O7S (487.18490840000004)
Gln Cys Thr His
C18H29N7O7S (487.18490840000004)
Gln Asp Glu Pro
C19H29N5O10 (487.19143340000005)
Gln Asp Pro Glu
C19H29N5O10 (487.19143340000005)
Gln Glu Asp Pro
C19H29N5O10 (487.19143340000005)
Gln Glu Pro Asp
C19H29N5O10 (487.19143340000005)
Gln Phe Gly His
Gln Phe His Gly
Gln Gly Phe His
Gln Gly His Phe
Gln His Cys Thr
C18H29N7O7S (487.18490840000004)
Gln His Phe Gly
Gln His Gly Phe
Gln His Thr Cys
C18H29N7O7S (487.18490840000004)
Gln Pro Asp Glu
C19H29N5O10 (487.19143340000005)
Gln Pro Glu Asp
C19H29N5O10 (487.19143340000005)
Gln Thr Cys His
C18H29N7O7S (487.18490840000004)
Gln Thr His Cys
C18H29N7O7S (487.18490840000004)
Ser His Met Asn
C18H29N7O7S (487.18490840000004)
Ser His Asn Met
C18H29N7O7S (487.18490840000004)
Ser Met His Asn
C18H29N7O7S (487.18490840000004)
Ser Met Asn His
C18H29N7O7S (487.18490840000004)
Ser Asn His Met
C18H29N7O7S (487.18490840000004)
Ser Asn Met His
C18H29N7O7S (487.18490840000004)
Thr Cys His Lys
C19H33N7O6S (487.2212918000001)
Thr Cys His Gln
C18H29N7O7S (487.18490840000004)
Thr Cys Lys His
C19H33N7O6S (487.2212918000001)
Thr Cys Gln His
C18H29N7O7S (487.18490840000004)
Thr His Cys Lys
C19H33N7O6S (487.2212918000001)
Thr His Cys Gln
C18H29N7O7S (487.18490840000004)
Thr His Lys Cys
C19H33N7O6S (487.2212918000001)
Thr His Gln Cys
C18H29N7O7S (487.18490840000004)
Thr Lys Cys His
C19H33N7O6S (487.2212918000001)
Thr Lys His Cys
C19H33N7O6S (487.2212918000001)
Thr Gln Cys His
C18H29N7O7S (487.18490840000004)
Thr Gln His Cys
C18H29N7O7S (487.18490840000004)
Trp Ala Asp Pro
Trp Ala Pro Asp
Trp Asp Ala Pro
Trp Asp Pro Ala
Trp Glu Gly Pro
Trp Glu Pro Gly
Trp Gly Glu Pro
Trp Gly Pro Glu
Trp Pro Ala Asp
Trp Pro Asp Ala
Trp Pro Glu Gly
Trp Pro Gly Glu
Dasatinib
C22H26ClN7O2S (487.1557126000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Estriol 16α-(β-D-glucuronide) sodium salt
C24H32NaO9 (487.19439220000004)
Benzyl 2-Deoxy-2-phthalimido-4,6-O-benzylidene--D-glucopyranoside
Avitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Zoliflodacin
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic D004791 - Enzyme Inhibitors
2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(3-methoxyphenyl)propan-2-yl]acetamide
C25H21F4N3O3 (487.15189640000006)
Dacomitinib monohydrate
C24H27ClFN5O3 (487.1786354000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Valemetostat
C26H34ClN3O4 (487.2237714000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor
Zotatifin
C28H29N3O5 (487.21071040000004)
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-[1-(4-Carbamimidoyl-benzylcarbamoyl)-3-methylsulfanyl-propyl]-3-hydroxy-2-propoxyamino-butyramid
C20H33N5O5S2 (487.19230080000006)
(6S)-N-[(2S,3R,6R,7R)-3-(Acetyloxymethyl)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]octan-7-yl]-6-[(2-aminoacetyl)amino]-7-hydroxy-7-oxoheptanimidate
Sarecycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D003879 - Dermatologic Agents
Pemigatinib
C24H27F2N5O4 (487.2031006000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
2,2,2-Trifluoro-N-((1R,2S)-1-((1-(4-fluorophenyl)-1H-indazol-5-yl)oxy)-1-(3-methoxyphenyl)-2-propanyl)acetamide
C25H21F4N3O3 (487.15189640000006)
(+)-Myxothiazol
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
N-[(E)-2-[5-(1,3-benzothiazol-2-yl)-3-ethyl-1-phenylbenzimidazol-3-ium-2-yl]ethenyl]-N-methylaniline
C31H27N4S+ (487.19563220000003)
sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(2-oxo-2,5-dihydro-1H-pyrrol-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
C25H38NNaO5S (487.2368258000001)
A natural product found in Coscinoderma species.
2-[4-[1-[(2-fluorophenyl)methyl]-2,4-dioxo-3-quinazolinyl]phenyl]-N-(2-oxolanylmethyl)acetamide
C28H26FN3O4 (487.19072480000005)
(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid
C27H29N5O4 (487.22194340000004)
1-(1-tert-butyl-5-tetrazolyl)-N-[(4-fluorophenyl)methyl]-N-(2-furanylmethyl)-1-[4-(trifluoromethyl)phenyl]methanamine
N,N-dimethyl-3-[[4-(4-nitrophenyl)-1-piperazinyl]-oxomethyl]-4-(1-pyrrolidinyl)benzenesulfonamide
C23H29N5O5S (487.18893040000006)
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide
C24H29N3O6S (487.17769740000006)
(2R,3S,3aS,5R,6R,7S,9aS)-5-[(2R,3E,5E,7E)-7-(2,4-dioxopyrrolidin-3-ylidene)-4-methyl-7-oxidohepta-3,5-dien-2-yl]-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocine-3-carboxylate
C25H29NO9-2 (487.18422240000007)
alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-D-galactose
alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactose
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
C28H29N3O5 (487.21071040000004)
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
C28H29N3O5 (487.21071040000004)
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
(2S)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
(2R)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[2-[(2S,5R,6S)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-3-piperidin-1-ylpropanamide
C22H34ClN3O5S (487.1907584000001)
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
(2S,3S,3aR,9bR)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
(2S,3S,3aR,9bR)-N-cyclobutyl-3-(hydroxymethyl)-7-(4-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
C25H33N3O5S (487.2140808000001)
(2R)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
(2S)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
(2S)-2-[(4S,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
(2R)-2-[(4S,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
(2S)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)carbamoylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[2-[(2R,5R,6S)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-3-piperidin-1-ylpropanamide
C22H34ClN3O5S (487.1907584000001)
N-[2-[(2S,5S,6S)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
C22H34ClN3O5S (487.1907584000001)
N-[2-[(2S,5R,6R)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-3-piperidin-1-ylpropanamide
C22H34ClN3O5S (487.1907584000001)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
C28H29N3O5 (487.21071040000004)
(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(1-methylimidazol-4-yl)sulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H29N5O5S (487.18893040000006)
(1R,9S,10S,11S)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-5-(3-methoxyphenyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H29N3O6S (487.17769740000006)
(2R,3R,3aS,9bS)-N-cyclobutyl-3-(hydroxymethyl)-7-(4-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
(2R)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O5S (487.2140808000001)
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
C25H33N3O5S (487.2140808000001)
3,3,3-trifluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[2-[(2S,5S,6R)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
C22H34ClN3O5S (487.1907584000001)
N-[2-[(2R,5S,6S)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
C22H34ClN3O5S (487.1907584000001)
2-[(1R,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-N,N-dimethyl-12-(1-methylimidazol-4-yl)sulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H29N5O5S (487.18893040000006)
(1S,9R,10R,11R)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-5-(3-methoxyphenyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H29N3O6S (487.17769740000006)
[(1R)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone
C24H26FN3O5S (487.1577118000001)
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[(3-methoxyanilino)-oxomethyl]amino]-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[2-[(2R,5R,6R)-5-[(3-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
C22H34ClN3O5S (487.1907584000001)
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(phenylmethyl)acetamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-phenylethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C28H29N3O5 (487.21071040000004)
2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C25H30ClN3O5 (487.18738800000006)
N-[(2R,4aS,12aS)-2-[2-(2,6-difluoroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]propanamide
C25H27F2N3O5 (487.1918676000001)
(3S,6aS,8R,10aS)-8-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-3-hydroxy-N-propyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(2R,3R,3aS,9bS)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methylsulfonyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O6S (487.17769740000006)
3-[4-[(8R,9R,10R)-6-(benzenesulfonyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
C28H29N3O3S (487.1929524000001)
[(1R)-1-(3-fluorophenyl)sulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H30FN3O4S (487.19409520000005)
[(1S)-1-(3-fluorophenyl)sulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H30FN3O4S (487.19409520000005)
[(1S)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(4-fluorophenyl)methanone
C24H26FN3O5S (487.1577118000001)
3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-D-galacto-hexopyranose
3,5-dideoxy-5-glycolamido-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-alpha-D-galacto-hexopyranose
(1S,9R,10R,11R)-N-cyclobutyl-10-(hydroxymethyl)-12-(1-methylimidazol-4-yl)sulfonyl-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H29N5O5S (487.18893040000006)
1-Benzyl-5-(3,4-dimethoxyphenyl)-8,8-dimethyl-5,5a,7,9-tetrahydropyrimido[4,5-b]quinoline-2,4,6-trione
C28H29N3O5 (487.21071040000004)
(1R,9S,10S,11S)-N-cyclobutyl-10-(hydroxymethyl)-12-(1-methylimidazol-4-yl)sulfonyl-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H29N5O5S (487.18893040000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H29N3O9S (487.16244240000003)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] nonanoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
goralatide
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors C26170 - Protective Agent
nocamycin E(2-)
C25H29NO9 (487.18422240000007)
A monocarboxylic acid anion that is a dianion resulting from the deprotonation of the carboxy group and the enol group of nocamycin E. The major species at pH 7.3.
AZD-8529
C24H24F3N5O3 (487.18311500000004)
AZD-8529 is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.
Fulimetibant
C25H21F4N3O3 (487.15189640000006)
Fulimetibant is a bradykinin receptor antagonist[1].
(9s,15e,20r)-5,8,18,21-tetrahydroxy-20-methyl-6-(sec-butyl)-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C21H33N3O6S2 (487.18106780000005)
(2e,4s,5r,6e)-3,5-dimethoxy-4-methyl-7-(2-{2-[(2r,3z,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
(2e,4e,6r)-n-[(1s,2s,3s,5s,9r)-1,7-dichloro-2,5-dihydroxy-9-methoxy-8-oxobicyclo[3.3.1]non-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
n-{1,7-dichloro-2,5-dihydroxy-9-methoxy-8-oxobicyclo[3.3.1]non-6-en-3-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
(2e,4e,6r)-n-[(1s,2r,3s,5s,9s)-1,7-dichloro-2,5-dihydroxy-9-methoxy-8-oxobicyclo[3.3.1]non-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
3-{[3-(carboxymethyl)-9,10a-dihydroxy-1-methyl-5,10-dioxo-octahydro-1h-naphtho[2,3-c]pyran-4a-yl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid
C21H29NO10S (487.1512094000001)
2-[(1-{10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene}ethyl)amino]-5-methoxy-5-oxopentanoic acid
(2s,4'ar,5'r,6's,8'ar)-2',8'a-dimethyl-6'-(prop-1-en-2-yl)-6-(pyridin-3-yl)-4'a,6',7',8'-tetrahydro-3h,4'h-dispiro[furo[3,2-c]pyran-2,1'-naphthalene-5',3''-oxane]-4,6''-dione
C30H33NO5 (487.23586080000007)
(2e,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-(2-{2-[(2s,3e,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
(2e,4e,6r)-n-[(2s,3s,4ar,8s,8as)-6,8-dichloro-4a-hydroxy-2-methoxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
(1r,12r,14s)-16-hydroxy-14-[(2r,4s)-4-isopropyl-5-oxo-1-phenylimidazolidin-2-yl]-12,14-dimethyl-13-oxa-2,10,17-triazatetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadeca-4,6,8,10,16-pentaen-3-one
C27H29N5O4 (487.22194340000004)
(2s,4'ar,5's,6's,8'ar)-2',8'a-dimethyl-6'-(prop-1-en-2-yl)-6-(pyridin-3-yl)-4'a,6',7',8'-tetrahydro-3h,4'h-dispiro[furo[3,2-c]pyran-2,1'-naphthalene-5',3''-oxane]-4,6''-dione
C30H33NO5 (487.23586080000007)
(9r,9as)-9-hydroxy-9-{[(1s,4r)-3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2,2-dimethyl-1h,9ah-imidazo[1,2-a]indol-3-one
C27H29N5O4 (487.22194340000004)
3,5-dimethoxy-4-methyl-7-{2-[2-(7-methylocta-3,5-dien-2-yl)-1,3-thiazol-4-yl]-1,3-thiazol-4-yl}hepta-2,6-dienimidic acid
5,8,18,21-tetrahydroxy-20-methyl-6-(sec-butyl)-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C21H33N3O6S2 (487.18106780000005)
2-{[(4e)-7-(furan-3-yl)-1-hydroxy-4-methylhept-4-en-1-ylidene]amino}-4-{[hydroxy((5-methylhexyl)oxy)phosphoryl]oxy}butanoic acid
(2e,4e,6r)-n-[(1s,2r,3s,5s,9r)-1,7-dichloro-2,5-dihydroxy-9-methoxy-8-oxobicyclo[3.3.1]non-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
(1r,2r,5s,6r)-5-{5-[(1r,2r,4as,6r,8ar)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-1,4-dihydroxy-6-oxopyridin-3-yl}-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl acetate
C26H33NO8 (487.22060580000004)
(4r,5s,6e)-3,5-dimethoxy-4-methyl-7-(2-{2-[(2s,3e,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
(2s)-2-({1-[(2r)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene]ethyl}amino)-5-methoxy-5-oxopentanoic acid
2',8'a-dimethyl-6'-(prop-1-en-2-yl)-6-(pyridin-3-yl)-4'a,6',7',8'-tetrahydro-3h,4'h-dispiro[furo[3,2-c]pyran-2,1'-naphthalene-5',3''-oxane]-4,6''-dione
C30H33NO5 (487.23586080000007)
(4r,6s,9s,10r,11s,16s)-6-ethyl-4,16-dihydroxy-11-{[(2r,5r,6r)-5-hydroxy-6-methyloxan-2-yl]oxy}-4,8,10-trimethyl-2-azatetracyclo[7.6.1.0²,⁶.0¹²,¹⁶]hexadeca-1(15),7,12-triene-3,5,14-trione
C26H33NO8 (487.22060580000004)
2-[(1-{10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),4,6,9,11-pentaen-4-yl}ethylidene)amino]-5-methoxy-5-oxopentanoic acid
5-[5-(2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)-1,4-dihydroxy-6-oxopyridin-3-yl]-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl acetate
C26H33NO8 (487.22060580000004)
(2s)-2-[(e)-{1-[(2r)-10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),4,6,9,11-pentaen-4-yl]ethylidene}amino]-5-methoxy-5-oxopentanoic acid
(9s,9ar)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2,2-dimethyl-1h,9ah-imidazo[1,2-a]indol-3-one
C27H29N5O4 (487.22194340000004)
n-(6,8-dichloro-4a-hydroxy-2-methoxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-3-yl)-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
(2e,6e)-3,5-dimethoxy-4-methyl-7-(2-{2-[(3e,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
(9r,9ar)-9-hydroxy-9-{[(1s,4r)-3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2,2-dimethyl-1h,9ah-imidazo[1,2-a]indol-3-one
C27H29N5O4 (487.22194340000004)
(2e,4e,6r)-n-[(2s,4r,4as,8s,8as)-6,8-dichloro-4a-hydroxy-2-methoxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
(2e,4e,6r)-n-[(2r,3s,5r,9r,10s)-7,9-dichloro-10-hydroxy-2-methoxy-8-oxo-1-oxaspiro[4.5]dec-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
9-hydroxy-9-({3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-2,2-dimethyl-1h,9ah-imidazo[1,2-a]indol-3-one
C27H29N5O4 (487.22194340000004)
(2e,4e,6r)-n-[(1s,2s,3s,5s,9s)-1,7-dichloro-2,5-dihydroxy-9-methoxy-8-oxobicyclo[3.3.1]non-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C24H35Cl2NO5 (487.18921600000004)
6-ethyl-4,16-dihydroxy-11-[(5-hydroxy-6-methyloxan-2-yl)oxy]-4,8,10-trimethyl-2-azatetracyclo[7.6.1.0²,⁶.0¹²,¹⁶]hexadeca-1(15),7,12-triene-3,5,14-trione
C26H33NO8 (487.22060580000004)
(2z,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-(2-{2-[(2s,3e,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
3,5-dimethoxy-4-methyl-7-(2-{2-[(5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
16-hydroxy-14-(4-isopropyl-5-oxo-1-phenylimidazolidin-2-yl)-12,14-dimethyl-13-oxa-2,10,17-triazatetracyclo[10.3.2.0²,¹¹.0⁴,⁹]heptadeca-4,6,8,10,16-pentaen-3-one
C27H29N5O4 (487.22194340000004)
(4r,6s,9s,10r,11s,16s)-6-ethyl-4,16-dihydroxy-11-{[(2r,5s)-5-hydroxy-6-methyloxan-2-yl]oxy}-4,8,10-trimethyl-2-azatetracyclo[7.6.1.0²,⁶.0¹²,¹⁶]hexadeca-1(15),7,12-triene-3,5,14-trione
C26H33NO8 (487.22060580000004)
1-[(3r,4as,10ar)-3-chloro-10a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-hydroxy-2,2,4a-trimethyl-5,8,10-trioxo-3h,4h-naphtho[2,3-b]pyran-9-ylidene]diazenium
1-[3-chloro-10a-(3,7-dimethylocta-2,6-dien-1-yl)-6-hydroxy-2,2,4a-trimethyl-5,8,10-trioxo-3h,4h-naphtho[2,3-b]pyran-9-ylidene]diazenium
(2e,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-(2-{2-[(3e,5e)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl}-1,3-thiazol-4-yl)hepta-2,6-dienimidic acid
(9r,9as)-9-hydroxy-9-{[(1s,4s)-3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2,2-dimethyl-1h,9ah-imidazo[1,2-a]indol-3-one
C27H29N5O4 (487.22194340000004)